Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) — Market Cap & Net Worth
Market Cap & Net Worth: Lotus Eye Hospital and Institute Limited (LOTUSEYE)
Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) has a market capitalization of $26.73 Million (Rs2.47 Billion) as of May 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #24089 globally and #1334 in its home market, demonstrating a -0.08% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lotus Eye Hospital and Institute Limited's stock price Rs118.87 by its total outstanding shares 20796330 (20.80 Million). Analyse Lotus Eye Hospital and Institute Limited cash conversion from operations to see how efficiently the company converts income to cash.
Lotus Eye Hospital and Institute Limited Market Cap History: 2015 to 2026
Lotus Eye Hospital and Institute Limited's market capitalization history from 2015 to 2026. Data shows growth from $5.07 Million to $26.73 Million (23.58% CAGR).
Lotus Eye Hospital and Institute Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lotus Eye Hospital and Institute Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.05x
Lotus Eye Hospital and Institute Limited's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.63x
Lotus Eye Hospital and Institute Limited's market cap is 3.63 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $6.08 Million | $311.32 Million | $1.01 Million | 0.02x | 6.03x |
| 2017 | $7.26 Million | $335.34 Million | $4.44 Million | 0.02x | 1.63x |
| 2018 | $6.24 Million | $352.75 Million | $17.47 Million | 0.02x | 0.36x |
| 2019 | $4.97 Million | $379.79 Million | $7.08 Million | 0.01x | 0.70x |
| 2020 | $7.28 Million | $399.81 Million | $10.65 Million | 0.02x | 0.68x |
| 2021 | $11.52 Million | $323.59 Million | $15.68 Million | 0.04x | 0.73x |
| 2022 | $17.12 Million | $389.10 Million | $29.84 Million | 0.04x | 0.57x |
| 2023 | $18.76 Million | $470.44 Million | $40.77 Million | 0.04x | 0.46x |
| 2024 | $14.99 Million | $482.10 Million | $29.14 Million | 0.03x | 0.51x |
| 2025 | $26.82 Million | $495.62 Million | $7.39 Million | 0.05x | 3.63x |
Competitor Companies of LOTUSEYE by Market Capitalization
Companies near Lotus Eye Hospital and Institute Limited in the global market cap rankings as of May 4, 2026.
Key companies related to Lotus Eye Hospital and Institute Limited by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #256 globally with a market cap of $96.85 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #962 globally with a market cap of $27.16 Billion USD ( €23.23 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #972 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1292 globally with a market cap of $19.57 Billion USD ( RM77.93 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #256 | HCA Holdings Inc | NYSE:HCA | $96.85 Billion | $433.09 |
| #962 | Fresenius SE & Co. KGaA | XETRA:FRE | $27.16 Billion | €41.25 |
| #972 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1292 | IHH Healthcare Bhd | KLSE:5225 | $19.57 Billion | RM8.82 |
Lotus Eye Hospital and Institute Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Lotus Eye Hospital and Institute Limited's market cap moved from $5.07 Million to $ 26.73 Million, with a yearly change of 23.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs26.73 Million | -0.31% |
| 2025 | Rs26.82 Million | +78.93% |
| 2024 | Rs14.99 Million | -20.10% |
| 2023 | Rs18.76 Million | +9.58% |
| 2022 | Rs17.12 Million | +48.59% |
| 2021 | Rs11.52 Million | +58.35% |
| 2020 | Rs7.28 Million | +46.36% |
| 2019 | Rs4.97 Million | -20.39% |
| 2018 | Rs6.24 Million | -13.98% |
| 2017 | Rs7.26 Million | +19.45% |
| 2016 | Rs6.08 Million | +19.96% |
| 2015 | Rs5.07 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Lotus Eye Hospital and Institute Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $26.73 Million USD |
| MoneyControl | $26.73 Million USD |
| MarketWatch | $26.73 Million USD |
| marketcap.company | $26.73 Million USD |
| Reuters | $26.73 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Lotus Eye Hospital and Institute Limited
Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor las… Read more